Background: Use of autologous tissue is ideal in breast reconstruction; however, insufficient donor tissue and surgical and donor-site morbidity all limit its use. Tissue engineering could provide replacement tissue, but only if vascularization of large tissue volumes is achievable.
Authors: Findlay, Michael W. M.B.B.S., Ph.D.; Dolderer, Juergen H. M.D.; Trost, Nicholas M.B.B.S.; Craft, Randall O. M.D.; Cao, Yang B.E.(Chem.), Ph.D.; Cooper-White, Justin B.E.(Chem.), Ph.D.; Stevens, Geoffrey B.E.(Chem.), Ph.D.; Morrison, Wayne A. M.D.Author Information Plastic and Reconstructive Surgery: December 2011 – Volume 128 – Issue 6 – p 1206-1215doi: 10.1097/PRS.0b013e318230c5b2
Browse Similar Papers
20 Sep 2022
Prehabilitation induces endothelial progenitor cell mobilisation in patients undergoing major surgery
Prehabilitation induces endothelial progenitor cell mobilisation in patients undergoing major surgery - Dataset of a clinical trial
10 Feb 2021
Living Biologic Pumps for Systemic Delivery of Human Coagulation Factor IX
Creation of Living Biologic Pumps for Systemic Delivery of Human Coagulation Factor IX using Minicircle DNA.
10 Feb 2019
Breast Reconstruction using Gene Therapy
Therapeutic Breast Reconstruction using Gene Therapy Delivered IFN-gamma Immunotherapy